Literature DB >> 11181426

Release of amines from acidified stores following accumulation by Transport-P.

S Al-Damluji1, W B Shen.   

Abstract

1. Transport-P is an uptake process for amines in peptidergic neurones of the hypothalamus. It differs from other uptake processes by its anatomical location in post-synaptic neurones, its functional properties and by the structure of its ligands. Transport-P accumulates amines in intracellular vesicles, derives its energy from the electrochemical proton gradient and is linked to vacuolar-type ATPase (V-ATPase). Transport-P is blocked by antidepressants. We have now studied the release of amines following uptake by Transport-P in a cell line of hypothalamic peptidergic neurones. 2. Release of prazosin was not inhibited by the antidepressant desipramine; as Transport-P is blocked by desipramine, this indicated that amines are released by a mechanism which is independent of Transport-P. 3. Release of prazosin was sensitive to temperature and conformed to the Arrhenius equation. Release was minimal in the range 0-25 degrees C but accelerated exponentially at higher temperatures up to 33 degrees C. The activation energy for the release of prazosin is 83.1 kJ x mol(-1), corresponding to a temperature quotient (Q10) value of 3. 4. Release was accelerated by the organic base chloroquine, the ionophore monensin, bafilomycinA1 which inhibits V-ATPase and by increasing extracellular pH. Thus, retention of prazosin requires an intracellular proton gradient which is generated by V-ATPase. 5. Fluorescence microscopy demonstrated that release of BODIPY FL prazosin was temperature dependent and was accelerated by chloroquine and monensin. 6. Thus, following uptake by Transport-P, amines are accumulated in acidified intracellular stores. Their retention in peptidergic neurones requires intracellular acidity. The amines are released by a temperature-dependent process which is resistant to antidepressants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11181426      PMCID: PMC1572617          DOI: 10.1038/sj.bjp.0703872

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  Visual detection of transport-P in peptidergic neurones.

Authors:  S al-Damluji; D Porter; L Z Krsmanovic; J R Knutson; I J Kopin
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

2.  INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN THE INTACT RAT BRAIN BY IMIPRAMINE AND STRUCTURALLY RELATED COMPOUNDS.

Authors:  J GLOWINSKI; J AXELROD
Journal:  Nature       Date:  1964-12-26       Impact factor: 49.962

Review 3.  The role of vesicular transport proteins in synaptic transmission and neural degeneration.

Authors:  Y Liu; R H Edwards
Journal:  Annu Rev Neurosci       Date:  1997       Impact factor: 12.449

Review 4.  Permeation properties of neurotransmitter transporters.

Authors:  H A Lester; S Mager; M W Quick; J L Corey
Journal:  Annu Rev Pharmacol Toxicol       Date:  1994       Impact factor: 13.820

5.  The extraneuronal transporter for monoamine transmitters exists in cells derived from human central nervous system glia.

Authors:  H Russ; K Staust; F Martel; M Gliese; E Schomig
Journal:  Eur J Neurosci       Date:  1996-06       Impact factor: 3.386

6.  Chimeric human and rat serotonin transporters reveal domains involved in recognition of transporter ligands.

Authors:  E L Barker; H L Kimmel; R D Blakely
Journal:  Mol Pharmacol       Date:  1994-11       Impact factor: 4.436

7.  Functional properties of the uptake of amines in immortalised peptidergic neurones (transport-P).

Authors:  S Al-Damluji; I J Kopin
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

8.  Binding and competitive inhibition of amine uptake at postsynaptic neurones (transport-P) by tricyclic antidepressants.

Authors:  S Al-Damluji; I J Kopin
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

9.  2,4-Diamino-6,7-dimethoxyquinazolines. 2. 2-(4-Carbamoylpiperidino) derivatives as alpha 1-adrenoceptor antagonists and antihypertensive agents.

Authors:  V A Alabaster; S F Campbell; J C Danilewicz; C W Greengrass; R M Plews
Journal:  J Med Chem       Date:  1987-06       Impact factor: 7.446

10.  Structural properties of phenylethylamine derivatives which inhibit transport-P in peptidergic neurones.

Authors:  S Al-Damluji; I J Kopin
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.